Life Sciences

Start-Up Pursuit Vascular Raises $750K, Plans $2M Round

The funds will be used for intellectual property costs and to prepare for clinical trials that will bring the company one step closer to gaining regulatory approval for its first product-which was designed to reduce the risk of life-threatening, catheter-related infections in hemodialysis patients.

MN Firm Osprey Medical Raises $20M in Australian IPO

The medical device company will use the funds to launch its product in Europe and to conduct a clinical trial in the United States.

Despite St. Jude Protest, Medical Journal Defends Article

St. Jude Medical wants a recently published article retracted, calling it a "biased analysis." But Douglas Zipes, managing editor of the online journal that published the article, said that's "not going to happen."

Small Science, Tech Cos. Get Matching Funds for Internships

Participating businesses receive up to $2,500 in matching funds for wages paid to student interns hired through a new program called SciTechsperience.

New Workspace Caters to Entrepreneurs, Other "Makers"

The Mill is a new collaborative workspace that gives members access to tools and equipment that they don't have access to at home, including 3-D printers, computers with design and drafting software, industrial sewing machines, and a metal shop.

Supreme Court Sides with Mayo in Patent Battle

The court determined that Prometheus' blood test involved naturally occurring phenomena, and its patents are therefore invalid; the ruling is expected to have broad implications in the scientific community.

Kips Bay to Again Seek Approval for U.S. Clinical Trial

The Plymouth-based company said it has gathered additional information on its eSVS Mesh device in order to address questions that regulators had raised.

MN Co. Launches IPO, Will Trade on Australian Exchange

Eden Prairie-based Osprey Medical hopes to raise approximately $21.2 million through an initial public offering launched Thursday and expects to start trading on the Australian Securities Exchange by mid-April.

Former Medtronic CEO to Chair New Med-Tech Initiative

Bill Hawkins, who served as CEO of Medtronic from 2007 to 2011, has been tapped as the chairman of a new public-private partnership that aims to establish a regulatory science center in Minnesota.

U of M Start-Up Orasi Medical Ceases Operations

According to MedCity News, the promising St. Louis Park-based company was marketing its technology to drug companies and had inked licensing deals with pharma giants like Novartis.

     |   |   |  4  |   

Upcoming Events: Life Sciences

• See All Life Sciences Events

Related Lists

Most Popular

Current Issue

June

Read this month's issue of Twin Cities Business.